Bayshore Pharms Llc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BAYSHORE PHARMS LLC, and what generic and branded alternatives to BAYSHORE PHARMS LLC drugs are available?
BAYSHORE PHARMS LLC has nine approved drugs.
Drugs and US Patents for Bayshore Pharms Llc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayshore Pharms Llc | PINDOLOL | pindolol | TABLET;ORAL | 211712-002 | Aug 1, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Bayshore Pharms Llc | PINDOLOL | pindolol | TABLET;ORAL | 211712-001 | Aug 1, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Bayshore Pharms Llc | ETODOLAC | etodolac | TABLET, EXTENDED RELEASE;ORAL | 212263-003 | Nov 24, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Bayshore Pharms Llc | METOLAZONE | metolazone | TABLET;ORAL | 214799-003 | Mar 30, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Bayshore Pharms Llc | ORPHENADRINE CITRATE | orphenadrine citrate | TABLET, EXTENDED RELEASE;ORAL | 091158-001 | Jul 27, 2012 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Bayshore Pharms Llc | KETOTIFEN FUMARATE | ketotifen fumarate | SOLUTION/DROPS;OPHTHALMIC | 204059-001 | Jun 1, 2020 | OTC | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.